Novartis AG
F:NOT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novartis AG
F:NOT
|
CH |
|
S
|
SLB NV
XMUN:SCL
|
US |
|
DSV A/S
F:DS8
|
DK |
|
A
|
Atlas Arteria Group
F:M82
|
AU |
|
Coloured Ties Capital Inc
XTSX:TIE
|
CA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NOT's stock price target?
Price Target
140.04
EUR
According to Wall Street analysts, the average 1-year price target for 
NOT is 140.04 EUR with a low forecast of 111.24 EUR and a high forecast of 168.41 EUR.
What is the Revenue forecast for Novartis AG?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 8 years is 3%.
What is the Gross Profit forecast for Novartis AG?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 8 years is 4%.
What is the Operating Income forecast for Novartis AG?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 6%.
What is the Pre-Tax Income forecast for Novartis AG?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 3%. The projected CAGR for the next 3 years is 14%.
What is the Net Income forecast for Novartis AG?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 8 years is 7%.